Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis

被引:26
|
作者
Grzanka, Alicja [1 ]
Misiolek, Maciej [2 ]
Golusinski, Wojciech [3 ]
Jarzab, Jerzy [1 ]
机构
[1] Med Univ Silesia, Clin Dept Internal Dis Dermatol & Allergol, PL-41800 Katowice, Poland
[2] Med Univ Silesia, Clin Dept Laryngol, PL-41800 Katowice, Poland
[3] Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg & Laryngol Oncol, Poznan, Poland
关键词
Glucocorticoids; Nongenomic and genomic action; Nasal polyps; Rhinitis; FLUTICASONE PROPIONATE; IN-VITRO; RECEPTOR; RHINITIS; UPDATE; DEXAMETHASONE; MANAGEMENT; SPRAY;
D O I
10.1007/s00405-010-1330-z
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Intra-nasal glucocorticoids are the most effective drugs available for rhinosinusitis and nasal polyposis treatment. Their effectiveness depends on many factors and not all of them have been well recognized so far. The authors present the basic information on molecular mechanisms of glucocorticoid action, direct and indirect effects of glucocorticoids on transcription of genes encoding inflammatory mediators. They focus on recently proved nongenomic mechanisms which appear quickly, from several seconds to minutes after glucocorticoid administration and discuss clinical implications resulting from this knowledge. Discovery of nongenomic glucocorticoid actions allows for better use of these drugs in clinical practice.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [41] Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis
    Gillespie, MB
    Osguthorpe, JD
    CURRENT ALLERGY AND ASTHMA REPORTS, 2004, 4 (06) : 478 - 485
  • [42] Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply
    Gevaert, Philippe
    Corren, Jonathan
    Mullol, Joaquim
    Han, Joseph
    Lee, Stella E.
    Ligueros-Saylan, Monica
    Wong, Kit
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (01) : 413 - 414
  • [43] Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis
    M. Boyd Gillespie
    J. David Osguthorpe
    Current Allergy and Asthma Reports, 2004, 4 : 478 - 485
  • [44] Postoperative quality of life in chronic rhinosinusitis with nasal polyposis
    De Vilhena, Ditza
    Duarte, Delfim
    Lopes, Gustavo
    REVISTA ORL, 2016, 7 (01) : 17 - 22
  • [45] Role of Biologics in Chronic Rhinosinusitis with nasal Polyposis (CRSwNP)
    Foerster, Ulrike
    Klimek, Ludger
    ALLERGOLOGIE, 2022, 45 (05) : 333 - 333
  • [46] Investigation of fatigue in patients with chronic rhinosinusitis with nasal polyposis
    Fraczek, Marcin
    Pieczynska, Joanna
    Oleszkiewicz, Anna
    Resler, Katarzyna
    Zablocka-Slowinska, Katarzyna
    Zatonski, Tomasz
    FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR, 2020, 8 (03): : 156 - 166
  • [47] The role of fungus in the etiology of chronic rhinosinusitis and nasal polyposis
    Sapci, T.
    Fethallah, B.
    Karavus, A.
    Mercangoez, E.
    Usta, C.
    Yazici, S.
    Akbulut, U. G.
    Bozkurt, S.
    TURKISH ARCHIVES OF OTORHINOLARYNGOLOGY, 2006, 44 (01) : 18 - 24
  • [48] Eosinophil paradox with mepolizumab in chronic rhinosinusitis with nasal polyposis
    Lipworth, Brian
    Chan, Rory
    Kuo, Chris RuiWen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (03) : 683 - 683
  • [49] Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis
    Yao, Yao
    Xie, Shumin
    Yang, Chunguang
    Zhang, Jianhui
    Wu, Xuewen
    Sun, Hong
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (10) : 3559 - 3566
  • [50] Multidisciplinary Management of Pediatric Chronic Rhinosinusitis with Nasal Polyposis
    Oh, Eugene
    Miller, Jessa E.
    Lee, Jivianne T.
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2024, 11 (02) : 34 - 48